Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Jazz Pharmaceuticals, Inc
WARNING LETTER
•Jazz Pharmaceuticals, Inc•May 6, 2011

Jazz Pharmaceuticals, Inc – FDA Warning Letter, May 6, 2011

Record Details

This FDA Warning Letter to Jazz Pharmaceuticals, Inc., dated October 11, 2011, resulted from an inspection conducted from April 27 to May 6, 2011. The inspection identified significant violations of Section 505(k) of the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. § 314.80, concerning postmarketing adverse drug experience reporting.

Key violations include: 1. **Failure to develop adequate written procedures for adverse drug experience (ADE) surveillance, receipt, evaluation, and reporting [21 C.F.R § 314.80(b)].** The firm lacked procedures to ensure ADEs were detected, identified, assessed, and reported, particularly from their contracted specialty pharmacy and call center, which acted as the sole distributor of Xyrem. There were no SOPs for monitoring the pharmacy's compliance or for evaluating ADEs against the U.S. package insert, ensuring accurate reporting to FDA Form 3500A, or investigating 15-day Alert reports. 2. **Failure to submit serious and unexpected ADE reports to FDA within 15 calendar days of initial receipt [21 C.F.R. § 314.80(c)(1)(i)].** The firm failed to submit 74 serious unexpected ADE reports for Xyrem between January

Company
Jazz Pharmaceuticals, Inc
Inspection date
May 6, 2011
Product type
Drugs
Office
Department of Health and Human Services
Person
  • Barbara J. Cassens (Director )
View Company Profile

ID · 8cafb83c-cd5b-47da-a409-e1b08601353a

Violation Codes8
21 U.S.C. 355(k)21 U.S.C. 355(k)(1)21 U.S.C. 331(e)21 CFR 314.8021 CFR 314.8121 CFR 314.80(b)21 CFR 314.80(c)(1)(ii)21 CFR 314.80(c)(1)(i)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Jazz Pharmaceuticals, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.